Rosa Farràs retweetledi
Desde @CIPFciencia recordamos que la investigación salva vidas, como la que se centra en mejores terapias para evitar recaídas y metástasis, que afectan al 30% de las pacientes. #DíaMundialdelCáncerdeMama
Español
Rosa Farràs
336 posts
Rosa Farràs
@RosaFarras
Biomedical scientist based in Valencia, Spain. Investigating oncogenic cell signaling and proteolysis. Enjoying science and climbing.
Valencia, Spain Katılım Ekim 2011
189 Takip Edilen217 Takipçiler
Thank you Ivan @iDikic2 we really enjoyed your company and seminar. It was a pleasure to have you at the @CIPFciencia
Ivan Đikić@iDikic2
Fantastic time in @CIPFciencia and #Valencia. Many thx to @RosaFarras for hospitality, great discussions, memorable dinner and perfect weather 😊😀 #Ubiquitination #Autophagy
English
We enjoyed today at CIPF the #FBRLectureSeries conference “Ubiquitin and Autophagy networks in regulation of health and disease” conducted by Prof. Ivan Dikic from @goetheuni Frankfurt about molecular mechanisms of the ubiquitin-proteasome system (UPS) and autophagy. @iDikic2
Valencia, Spain 🇪🇸 English
@CIPFciencia @goetheuni @iDikic2 @MPIbp @IBC2_GU @EMBO @EmboMolMed It has been a pleasure to listen to Ivan's fantastic ideas and discoveries. As always, your enthusiasm and dedication to excellent science shone through, thank you Ivan! #Science
English
Rosa Farràs retweetledi
Look at the wonderful image @juanes_lab @CIPFciencia. If you like, please click this link and Vote #3 ;;)))
focalplane.biologists.com/2024/09/25/vot…
FocalPlane@focalplane_jcs
It's time to pick your favourite image in our #JCSImagingSI cover competition. @EM_STP, @guijacquemet and @seemasainson have shortlisted their top 10 from all the fantastic images that were submitted. Which one is your favourite? focalplane.biologists.com/2024/09/25/vot…
English
Yes, I agree, we have had an excellent start to the 3 annual @ProteoCure meeting. I hope you enjoy the meeting and welcome to the MC!
Rune Busk Damgaard@rbdamgaard
In Warsaw this week for the @ProteoCure Annual Meeting. Marcin Drąg kicking off the scientific programme just now. Looking forward to several days of science on proteostasis, ubiquitin, and lots of other exciting things.
English
Congratulations Nik!!! Keep us updated on the progress with this drug 💪💪💪@ProteoCure
Nik Subramanian@NikSubramanian
We got in vitro results today that show that we've found a first-in-class, potent drug that we hope will be able to treat a wide variety of cancers. Took us a couple of months (v. ~3-10 years usually) and tested just 30 compounds (v. 100k+). Still work to do, but screw cancer.
English
@ContraCancerVAL @CIPFciencia @incliva_iis @_BIOTECMED @CBIT_upv @uchceu @Aquaservice @CECOTECoficial ¡Quiero expresar mi más sincero agradecimiento a @ContraCancerVAL por confiar en nosotros! ¡Gracias por su apoyo en el Día Mundial de la Investigación en Cáncer! 🙏🔬 #InvestigaciónEnCáncer
Español
🔬Con motivo del Día Mundial de la Investigación en Cáncer, @ContraCancerVAL ha otorgado seis ayudas postdoctorales para mejorar el abordaje del cáncer
Estos proyectos se desarrollarán en @CIPFciencia, @incliva_iis, @_BIOTECMED, @CBIT_upv y @uchceu.
👏¡Enhorabuena a todos!👏
Español
¡Gracias a @ContraCancerVAL por su confianza en la investigación en cáncer! Juntos, ganaremos esta batalla. 💪🔬#UnidosContraElCáncer
CIPF@CIPFciencia
Nuestro agradecimiento @ContraCancerVAL por confiar siempre en la investigación valenciana. Esta batalla la ganamos unidos/as. #LaInvestigaciónSalvaVidas #YoInvestigoContraElCáncer💚
Español
Rosa Farràs retweetledi
Felicidades @ContraCancerVAL por la fantástica nueva sede y su encomiable labor de acompañar a pacientes, sus familias y apoyar la investigación
#MásInvestigación #MejorSalud
Asociación Española Contra el Cáncer en Valencia@ContraCancerVAL
🔬🧬 Estamos ya en el evento #YoInvestigoContraElCáncer. Juntos, investigando frente al #cáncer.
Español
Congratulations on this work that raises important questions about current chemotherapy treatments and opens new avenues to target tumor cells @fjiborra #CancerResearch #ScientificBreakthrough
IBV-CSIC@IBV_CSIC
Investigación realizara por un equipo liderado por Francisco J. Iborra @fjiborra responsable de la Unidad de Ruido Biológico del @IBV_CSIC
English
@CorEuStem @BartVeys @COSTprogramme @HorizonEU It has been truly rewarding to engage and establish connections with a diverse range of captivating COST Actions focused on #Cancer. @ProteoCure @CIPFciencia @ConnectCost
English
Last week COST Connect Coordinating cancer research in Europe collaborating for progress hosted representatives from 20 CA, the president of ECL and the EC delegate. Their presentations and discussions opened new interaction between scientists in the field of cancer research.
English
Last week the #COSTConnect event on Coordinating cancer research in Europe was a great success!
Researchers, cancer patient organizations, and industry leaders came together to engage in insightful discussions about the challenges in cancer research. @ProteoCure @ConnectCost
English
Great meeting, excellent talks, wonderful place and atmosphere. Thank you ProteoCurers for being such nice people #Zagreb @ProteoCure
English
English
Your perseverance have paid off. Super congrats!!!
Juan Rodriguez Vita@J_RodriguezVita
Extremely happy to announce that a peer-reviewed version of this article has been just published in @NatureComms! Thanks a lot to @wiedmann_lena, Francesca De Angelis Rigotti, @Andreas73629100 and the rest of the collaborators. It was an amazing team! nature.com/articles/s4146…
English
Rosa Farràs retweetledi
I don’t usually post personal news but Clinicians have told us to pull every lever.
Our daughter has with #dipg Brain cancer. There is no cure and typically 9m life expectancy.
If anyone knows of trials then please get in contact! #braincancer #childrenscancer @CR_UK
English
0/6 Extra bonus‼️: our image (Luis’ design) selected as #cover for the current issue at @PNASNews
You can find our paper 👉🏻 pnas.org/doi/10.1073/pn…
Ismael Mingarro@IsmaelMingarro
Happy to see our work lead by @GerardDuart & #LuisMartinezGil @UV_EG in collaboration with #FleishmanLab @WeizmannScience finally published on line at @PNASNews: 1/5 Computational design of #BclxL inhibitors that target transmembrane domain interactions pnas.org/doi/10.1073/pn…
English